158 related articles for article (PubMed ID: 21654897)
1. Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana).
Liu G; Zeng T; Yu W; Yan N; Wang H; Cai SP; Pang IH; Liu X
Mol Vis; 2011; 17():1405-13. PubMed ID: 21654897
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of monkey intraocular pressure by rebound tonometer.
Yu W; Cao G; Qiu J; Liu X; Ma J; Li N; Yu M; Yan N; Chen L; Pang IH
Mol Vis; 2009 Oct; 15():2196-201. PubMed ID: 19898690
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.
Frenkel RE; Noecker RJ; Craven ER
Curr Med Res Opin; 2008 Apr; 24(4):919-23. PubMed ID: 18267054
[TBL] [Abstract][Full Text] [Related]
4. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
[TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
6. Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension.
Pfeiffer N;
Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):1065-71. PubMed ID: 21499770
[TBL] [Abstract][Full Text] [Related]
7. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.
Fellman RL; Sullivan EK; Ratliff M; Silver LH; Whitson JT; Turner FD; Weiner AL; Davis AA;
Ophthalmology; 2002 May; 109(5):998-1008. PubMed ID: 11986110
[TBL] [Abstract][Full Text] [Related]
8. The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma.
Shin J; Lee JW; Choi BS; Yun EY; Jung JH; Kim EA; Caprioli J
J Ocul Pharmacol Ther; 2014 Dec; 30(10):803-9. PubMed ID: 25285367
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of latanoprost versus travoprost assessed by daily intraocular pressure curve].
Santos HD; Fernandes TA; Souza CA; Cronemberger S; Calixto N
Arq Bras Oftalmol; 2009; 72(1):13-7. PubMed ID: 19347115
[TBL] [Abstract][Full Text] [Related]
10. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
[TBL] [Abstract][Full Text] [Related]
11. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
Ota T; Murata H; Sugimoto E; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma.
Holló G; Chiselita D; Petkova N; Cvenkel B; Liehneova I; Izgi B; Berta A; Szaflik J; Turacli E; Stewart WC
Eur J Ophthalmol; 2006; 16(6):816-23. PubMed ID: 17191187
[TBL] [Abstract][Full Text] [Related]
14. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.
Goldberg I; Cunha-Vaz J; Jakobsen JE; Nordmann JP; Trost E; Sullivan EK;
J Glaucoma; 2001 Oct; 10(5):414-22. PubMed ID: 11711841
[TBL] [Abstract][Full Text] [Related]
15. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC
Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390
[TBL] [Abstract][Full Text] [Related]
16. Effects of travoprost on aqueous humor dynamics in monkeys.
Toris CB; Zhan GL; Camras CB; McLaughlin MA
J Glaucoma; 2005 Feb; 14(1):70-3. PubMed ID: 15650608
[TBL] [Abstract][Full Text] [Related]
17. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
18. Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
Liu JH; Realini T; Weinreb RN
Ophthalmology; 2011 Oct; 118(10):1995-2000. PubMed ID: 21676464
[TBL] [Abstract][Full Text] [Related]
19. NCX 1741, a Novel Nitric Oxide-Donating Phosphodiesterase-5 Inhibitor, Exerts Rapid and Long-Lasting Intraocular Pressure-Lowering in Cynomolgus Monkeys.
Bastia E; Toris C; Bukowski JM; Brambilla S; Galli C; Almirante N; Bergamini MVW; Lucarini L; Navratil T; Impagnatiello F
J Ocul Pharmacol Ther; 2021 May; 37(4):215-222. PubMed ID: 33595367
[No Abstract] [Full Text] [Related]
20. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
